Cargando…

Genes and pathways underlying regional and cell type changes in Alzheimer's disease

BACKGROUND: Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of many cellular pathways, including synaptic transmission, cytoskeletal dynamics, energetics, and apoptosis. Despite known progression of AD pathologies, it is unclear how such striking regional vulnerabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Jeremy A, Woltjer, Randall L, Goodenbour, Jeff M, Horvath, Steve, Geschwind, Daniel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706780/
https://www.ncbi.nlm.nih.gov/pubmed/23705665
http://dx.doi.org/10.1186/gm452
_version_ 1782276404611645440
author Miller, Jeremy A
Woltjer, Randall L
Goodenbour, Jeff M
Horvath, Steve
Geschwind, Daniel H
author_facet Miller, Jeremy A
Woltjer, Randall L
Goodenbour, Jeff M
Horvath, Steve
Geschwind, Daniel H
author_sort Miller, Jeremy A
collection PubMed
description BACKGROUND: Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of many cellular pathways, including synaptic transmission, cytoskeletal dynamics, energetics, and apoptosis. Despite known progression of AD pathologies, it is unclear how such striking regional vulnerability occurs, or which genes play causative roles in disease progression. METHODS: To address these issues, we performed a large-scale transcriptional analysis in the CA1 and relatively less vulnerable CA3 brain regions of individuals with advanced AD and nondemented controls. In our study, we assessed differential gene expression across region and disease status, compared our results to previous studies of similar design, and performed an unbiased co-expression analysis using weighted gene co-expression network analysis (WGCNA). Several disease genes were identified and validated using qRT-PCR. RESULTS: We find disease signatures consistent with several previous microarray studies, then extend these results to show a relationship between disease status and brain region. Specifically, genes showing decreased expression with AD progression tend to show enrichment in CA3 (and vice versa), suggesting transcription levels may reflect a region's vulnerability to disease. Additionally, we find several candidate vulnerability (ABCA1, MT1H, PDK4, RHOBTB3) and protection (FAM13A1, LINGO2, UNC13C) genes based on expression patterns. Finally, we use a systems-biology approach based on WGCNA to uncover disease-relevant expression patterns for major cell types, including pathways consistent with a key role for early microglial activation in AD. CONCLUSIONS: These results paint a picture of AD as a multifaceted disease involving slight transcriptional changes in many genes between regions, coupled with a systemic immune response, gliosis, and neurodegeneration. Despite this complexity, we find that a consistent picture of gene expression in AD is emerging.
format Online
Article
Text
id pubmed-3706780
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37067802013-08-06 Genes and pathways underlying regional and cell type changes in Alzheimer's disease Miller, Jeremy A Woltjer, Randall L Goodenbour, Jeff M Horvath, Steve Geschwind, Daniel H Genome Med Research BACKGROUND: Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of many cellular pathways, including synaptic transmission, cytoskeletal dynamics, energetics, and apoptosis. Despite known progression of AD pathologies, it is unclear how such striking regional vulnerability occurs, or which genes play causative roles in disease progression. METHODS: To address these issues, we performed a large-scale transcriptional analysis in the CA1 and relatively less vulnerable CA3 brain regions of individuals with advanced AD and nondemented controls. In our study, we assessed differential gene expression across region and disease status, compared our results to previous studies of similar design, and performed an unbiased co-expression analysis using weighted gene co-expression network analysis (WGCNA). Several disease genes were identified and validated using qRT-PCR. RESULTS: We find disease signatures consistent with several previous microarray studies, then extend these results to show a relationship between disease status and brain region. Specifically, genes showing decreased expression with AD progression tend to show enrichment in CA3 (and vice versa), suggesting transcription levels may reflect a region's vulnerability to disease. Additionally, we find several candidate vulnerability (ABCA1, MT1H, PDK4, RHOBTB3) and protection (FAM13A1, LINGO2, UNC13C) genes based on expression patterns. Finally, we use a systems-biology approach based on WGCNA to uncover disease-relevant expression patterns for major cell types, including pathways consistent with a key role for early microglial activation in AD. CONCLUSIONS: These results paint a picture of AD as a multifaceted disease involving slight transcriptional changes in many genes between regions, coupled with a systemic immune response, gliosis, and neurodegeneration. Despite this complexity, we find that a consistent picture of gene expression in AD is emerging. BioMed Central 2013-05-25 /pmc/articles/PMC3706780/ /pubmed/23705665 http://dx.doi.org/10.1186/gm452 Text en Copyright © 2013 Miller et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Miller, Jeremy A
Woltjer, Randall L
Goodenbour, Jeff M
Horvath, Steve
Geschwind, Daniel H
Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title_full Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title_fullStr Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title_full_unstemmed Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title_short Genes and pathways underlying regional and cell type changes in Alzheimer's disease
title_sort genes and pathways underlying regional and cell type changes in alzheimer's disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706780/
https://www.ncbi.nlm.nih.gov/pubmed/23705665
http://dx.doi.org/10.1186/gm452
work_keys_str_mv AT millerjeremya genesandpathwaysunderlyingregionalandcelltypechangesinalzheimersdisease
AT woltjerrandalll genesandpathwaysunderlyingregionalandcelltypechangesinalzheimersdisease
AT goodenbourjeffm genesandpathwaysunderlyingregionalandcelltypechangesinalzheimersdisease
AT horvathsteve genesandpathwaysunderlyingregionalandcelltypechangesinalzheimersdisease
AT geschwinddanielh genesandpathwaysunderlyingregionalandcelltypechangesinalzheimersdisease